D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy (NCT06049758) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
Egypt80 participantsStarted 2024-01-02
Plain-language summary
Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-operative ICU admission, anastomotic leakage, lymph node harvesting in the final specimen, and six months follow up and overall survival time after 5-years
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with right-side colon cancer (caecum, ascending, or hepatic flexure)
* Diagnosed by CT entero-colonography
* Diagnosed by colonoscopy
* Diagnosed by biopsy.
Exclusion Criteria:
* Emergency surgery (obstruction, perforation with generalized peritonitis),
* Metastatic tumor diagnosed
* ASA score of IV or higher
* Need for more than one surgical procedure
* Conversion to open surgery
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of blood units needed
Timeframe: during the intervention/procedure/surgery
2
Number of post-operative ICU admission
Timeframe: immediately after the intervention/procedure/surgery
3
Number of anastomotic leakage
Timeframe: Within 30 days post-operative
4
Number of lymph node harvesting in the final specimen
Timeframe: 6 months post-operative
5
Number of postoperative outcomes
Timeframe: 6 months post-operative
Trial details
NCT IDNCT06049758
SponsorGeneral Committee of Teaching Hospitals and Institutes, Egypt